GE HealthCare Technologies Deferred Revenue increased by 2.8% to $2.15B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.0%, from $1.89B to $2.15B. Over 3 years (FY 2022 to FY 2025), Deferred Revenue shows an upward trend with a 3.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests strong sales of subscription-based services or bundled offerings, providing a predictable pipeline for future revenue recognition.
Represents cash payments received from customers in advance of the company fulfilling its performance obligations, speci...
High-growth software and services companies typically maintain larger deferred revenue balances relative to pure hardware manufacturers.
deferred_revenue_current| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.90B | $2.03B | $2.00B | $1.93B | $1.92B | $1.88B | $1.88B | $1.92B | $1.94B | $1.89B | $1.98B | $2.00B | $2.10B | $2.15B |
| QoQ Change | — | +7.1% | -1.4% | -3.8% | -0.5% | -2.0% | -0.2% | +2.1% | +1.5% | -2.8% | +4.8% | +1.2% | +4.6% | +2.8% |
| YoY Change | — | — | — | — | +1.2% | -7.5% | -6.3% | -0.6% | +1.3% | +0.5% | +5.5% | +4.5% | +7.8% | +14.0% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Service | $9.88B | $9.76B | $9.74B | $10.28B | $10.50B | $10.20B | $10.73B | $10.69B |
| Total | $1.88B | $1.92B | $1.94B | $1.89B | $1.98B | $2.00B | $2.10B | $2.15B |